top of page

CERNEVIT FOR INJECTION

Product details

Registration number: SIN11975P

Classification: General Sale List

Active ingredients:

  • ASCORBIC ACID
  • CHOLECALCIFEROL
  • COCARBOXYLASE TETRAHYDRATE EQV THIAMINE
  • CYANOCOBALAMIN
  • D-BIOTIN
  • DEXPANTHENOL EQV PANTOTHENIC ACID
  • DL ALPHA-TOCOPHEROL EQV ALPHA-TOCOPHEROL
  • FOLIC ACID
  • NICOTINAMIDE
  • PYRIDOXINE HCl EQV PYRIDOXINE
  • RETINOL PALMITATE EQV RETINOL
  • RIBOFLAVIN DIHYDRATED SODIUM PHOSPHATE EQV RIBOFLAVIN

Strength:

  • 125 mg/vial
  • 220 iu/vial
  • 3.51 mg/vial
  • 0.006 mg/vial
  • 0.069 mg/vial
  • 17.25 mg/vial
  • 11.2 iu/vial
  • 0.414 mg/vial
  • 46 mg/vial
  • 4.53 mg/vial
  • 3500 iu/vial
  • 4.14 mg/vial

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Registrant: BAXTER HEALTHCARE (ASIA) PTE LTD

ATC code: B05XC

HSA approval date: 5 June 2002

Manufacturer(s):

  • FAREVA PAU 1 (Sub-contractor)
  • Baxter S.A.

Manufacturing country/countries: FRANCE; BELGIUM

What are the HSA registration number and classification for CERNEVIT FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN11975P

Classification: General Sale List

Source for this answer

What active ingredients and strength are recorded for CERNEVIT FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • ASCORBIC ACID
  • CHOLECALCIFEROL
  • COCARBOXYLASE TETRAHYDRATE EQV THIAMINE
  • CYANOCOBALAMIN
  • D-BIOTIN
  • DEXPANTHENOL EQV PANTOTHENIC ACID
  • DL ALPHA-TOCOPHEROL EQV ALPHA-TOCOPHEROL
  • FOLIC ACID
  • NICOTINAMIDE
  • PYRIDOXINE HCl EQV PYRIDOXINE
  • RETINOL PALMITATE EQV RETINOL
  • RIBOFLAVIN DIHYDRATED SODIUM PHOSPHATE EQV RIBOFLAVIN

Strength:

  • 125 mg/vial
  • 220 iu/vial
  • 3.51 mg/vial
  • 0.006 mg/vial
  • 0.069 mg/vial
  • 17.25 mg/vial
  • 11.2 iu/vial
  • 0.414 mg/vial
  • 46 mg/vial
  • 4.53 mg/vial
  • 3500 iu/vial
  • 4.14 mg/vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for CERNEVIT FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Dosage form: INJECTION, POWDER, FOR SOLUTION

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for CERNEVIT FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Registrant: BAXTER HEALTHCARE (ASIA) PTE LTD

Source for this answer

Which manufacturers and countries are listed for CERNEVIT FOR INJECTION?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s):

  • FAREVA PAU 1 (Sub-contractor)
  • Baxter S.A.

Manufacturing country/countries: FRANCE; BELGIUM

Source for this answer

Where can I look up CERNEVIT FOR INJECTION in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN11975P or the exact product name CERNEVIT FOR INJECTION. The general register link does not preselect this product.

Source for this answer

What are the source dates for this CERNEVIT FOR INJECTION record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this CERNEVIT FOR INJECTION record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN11975P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page